Back to Search Start Over

Fertility sparing surgery for treatment of early-stage cervical cancer: Open vs. robotic radical trachelectomy

Authors :
Nick, Alpa M.
Frumovitz, Michael M.
Soliman, Pamela T.
Schmeler, Kathleen M.
Ramirez, Pedro T.
Source :
Gynecologic Oncology. Feb2012, Vol. 124 Issue 2, p276-280. 5p.
Publication Year :
2012

Abstract

Abstract: Objective: To compare the open versus robotic surgical approaches and provide surgical outcome data on patients who have undergone radical trachelectomy (RT). Methods: We identified patients who underwent open (ORT) or robotic radical trachelectomy (RRT) between September 2005 and June 2011. Tumor characteristics, perioperative, operative and obstetrical outcomes were analyzed. Results: Thirty-seven patients with early stage cervical cancer that desired future fertility underwent attempted radical trachelectomy, and 32 patients (20 with 1B1, 11 with 1A2, and 5 with 1A1 with LVSI/poorly differentiated histology) had successful completion of RT. Five (1 open/4 robotic) underwent conversion to radical hysterectomy secondary to close (<5mm) endocervical margin (p=0.08). The median age at diagnosis was 28.9years (range; 21.4–37.2), 70% were nulliparous, and 9 had a visible lesion. Twenty-five patients (68%) underwent ORT and 12 (32%) underwent RRT. RRT was associated with less blood loss (62.5mL vs. 300mL, p=0.0001) and decreased length of postoperative stay (1 vs. 4days, p<0.001), with no difference in operative time or histopathologic outcomes. Twenty-three patients (62%) had no residual cervical disease on final pathology. Common long-term morbidities were irregular menstrual bleeding or amenorrhea (25%), cerclage erosion (13%), or cervical stenosis (9%). Although there was a higher rate of conversion to hysterectomy in the robotic surgery cohort, rates of serious morbidities among the cohorts were comparable (robotic: 33% vs. open: 24%, p=0.70). Eleven (36%) patients are actively attempting pregnancy and three have achieved pregnancy. The median time of follow up is 17.0months (range 0.30–64.9months). There are no documented recurrences. Conclusions: RRT results in less blood loss and decreased length of hospital stay with no compromise in histopathologic outcomes. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
00908258
Volume :
124
Issue :
2
Database :
Academic Search Index
Journal :
Gynecologic Oncology
Publication Type :
Academic Journal
Accession number :
70946169
Full Text :
https://doi.org/10.1016/j.ygyno.2011.09.035